Your browser doesn't support javascript.
loading
Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.
Vigil, Adam; Estélles, Angeles; Kauvar, Lawrence M; Johnson, Scott K; Tripp, Ralph A; Wittekind, Michael.
Affiliation
  • Vigil A; ContraFect Corporation, Yonkers, New York, USA.
  • Estélles A; Trellis Bioscience, Menlo Park, California, USA.
  • Kauvar LM; Trellis Bioscience, Menlo Park, California, USA.
  • Johnson SK; University of Georgia, Department of Infectious Disease, Athens, Georgia, USA.
  • Tripp RA; University of Georgia, Department of Infectious Disease, Athens, Georgia, USA.
  • Wittekind M; ContraFect Corporation, Yonkers, New York, USA Michael.wittekind@olympicproteintechnologies.com.
Antimicrob Agents Chemother ; 62(5)2018 05.
Article in En | MEDLINE | ID: mdl-29507069
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza B virus / Orthomyxoviridae Infections / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza B virus / Orthomyxoviridae Infections / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2018 Document type: Article Affiliation country: Country of publication: